Literature DB >> 26405023

Eltrombopag in systemic lupus erythematosus with antiphospholipid syndrome: thrombotic events.

C Boulon1, M Vircoulon2, J Constans2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26405023     DOI： 10.1177/0961203315608257

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  4 in total

Review 1.  Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome.

Authors:  Andrew P Vreede; Paula L Bockenstedt; W Joseph McCune; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

2.  Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease.

Authors:  Juan Wang; Min Dai; Qiong Fu; Sheng Chen
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

Review 3.  Lupus thrombocytopenia: pathogenesis and therapeutic implications.

Authors:  Nikolaos Galanopoulos; Anna Christoforidou; Zoe Bezirgiannidou
Journal:  Mediterr J Rheumatol       Date:  2017-03-28

4.  Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura.

Authors:  Zayar Oo; Kapilkumar Manvar; Jen Chin Wang
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.